Representatives Probe CMS for Further Detail on New CAR-T Therapy Payment Agreement – AJMC.com Managed Markets Network
Representatives Probe CMS for Further Detail on New CAR-T Therapy Payment AgreementAJMC.com Managed Markets NetworkAfter CMS and Novartis devised an outcomes-based payment approach for the new chimeric antigen receptor (CAR)-T treatment tisagenlecleuce… Continue reading
